pharma · Menopause · Vulvovaginal Atrophy · TXMD
TherapeuticsMD
TherapeuticsMD clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Boca Raton, USA
- Employees
- 53
- Programs
- 6
- Drugs
- 6
- Patents
- 0
TherapeuticsMD projects
6 ClinicalTrials.gov programs sponsored by TherapeuticsMD.
TherapeuticsMD has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Estradiol
TherapeuticsMD
Menopause
2 trials -
Estradiol
TherapeuticsMD
Vulvovaginal Atrophy
1 trial -
Progesterone
TherapeuticsMD
Secondary Amenorrhea
1 trial -
oral estradiol 1.0 mg
TherapeuticsMD
Menopause
1 trial -
Segesterone Acetate and Ethinyl Estradiol
TherapeuticsMD
Contraception
1 trial -
Segesterone Acetate and Ethinyl Estradiol
TherapeuticsMD
Women
1 trial
Frequently asked questions
How many clinical projects does TherapeuticsMD have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.